Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

NCT02159573 · clinicaltrials.gov ↗

COMPLETED

Status

530

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

BIOLOGICAL: natalizumab
DRUG: dimethyl fumarate

Sponsor

Biogen